Non-alcoholic fatty liver disease and diabetes.

Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. · 2016

Read Non-alcoholic fatty liver disease and diabetes. by Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4943559.txt.

Description

Jonathan M. Hazlehurst and four co-authors review how non-alcoholic fatty liver disease and type 2 diabetes drive each other. Their review appeared in Metabolism in 2016. Fatty liver unrelated to alcohol is now common, and it often occurs with diabetes. Each condition makes the other worse. Together they raise the risk of diabetes complications in vessels large and small, and of severe liver outcomes such as cirrhosis, liver cancer, and death.

Weight loss and good blood sugar control remain the core of care, the authors say. They slow the disease before scarring sets in. Once cirrhosis develops, screening for its complications becomes the priority. Drug evidence is thin, drawn mostly from case series rather than strong trials. The authors sort the published data on diabetes drugs that may also help the liver. They call for well designed randomized trials with firm end points.

Catalog record

CREATORHazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4943559

Browse the full library · About the Tower of Babel